Complex Injectable Market - Global Outlook and Forecast 2022-2028

March 2022 | 71 pages | ID: CC21BCD779F6EN
Market Monitor Global

Abstracts

Complex injectable are designed to infuse drug through a hollow needle and a syringe which is penetrated through the skin into the body. Complex injectable market is gaining traction in the injectable therapies/infusion treatment owing to increase in use in life-threatening and chronic diseases treatments. The manufacturing of the complex injectable products is extremely complex and requires major investment. Since the injectables are highly toxic and infectious in nature, therefore a great level observation of quality and care is required during their manufacturing, packaging, distribution and storage.

This report contains market size and forecasts of Complex Injectable in global, including the following market information:

Global Complex Injectable Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Complex Injectable Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Complex Injectable companies in 2021 (%)

The global Complex Injectable market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bottles Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Complex Injectable include Eli Lilly, Pfizer, Teva Pharmaceutical Industries, Hospira, Hikma Pharmaceutical, Johnson & Johnson Pharmaceutical, Novo Nordisk and Abbvie, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Complex Injectable manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Complex Injectable Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Complex Injectable Market Segment Percentages, by Type, 2021 (%)

• Bottles
• Vials
• Ampules
• Cartridges

Global Complex Injectable Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Complex Injectable Market Segment Percentages, by Application, 2021 (%)

• Hospitals And Clinics
• Home Care Settings
• Online Pharmacies
• Others

Global Complex Injectable Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Complex Injectable Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Complex Injectable revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Complex Injectable revenues share in global market, 2021 (%)

Key companies Complex Injectable sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Complex Injectable sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Eli Lilly
• Pfizer
• Teva Pharmaceutical Industries
• Hospira
• Hikma Pharmaceutical
• Johnson & Johnson Pharmaceutical
• Novo Nordisk
• Abbvie

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Complex Injectable Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Complex Injectable Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL COMPLEX INJECTABLE OVERALL MARKET SIZE

2.1 Global Complex Injectable Market Size: 2021 VS 2028
2.2 Global Complex Injectable Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Complex Injectable Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Complex Injectable Players in Global Market
3.2 Top Global Complex Injectable Companies Ranked by Revenue
3.3 Global Complex Injectable Revenue by Companies
3.4 Global Complex Injectable Sales by Companies
3.5 Global Complex Injectable Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Complex Injectable Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Complex Injectable Product Type
3.8 Tier 1, Tier 2 and Tier 3 Complex Injectable Players in Global Market
  3.8.1 List of Global Tier 1 Complex Injectable Companies
  3.8.2 List of Global Tier 2 and Tier 3 Complex Injectable Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Complex Injectable Market Size Markets, 2021 & 2028
  4.1.2 Bottles
  4.1.3 Vials
  4.1.4 Ampules
  4.1.5 Cartridges
4.2 By Type - Global Complex Injectable Revenue & Forecasts
  4.2.1 By Type - Global Complex Injectable Revenue, 2017-2022
  4.2.2 By Type - Global Complex Injectable Revenue, 2023-2028
  4.2.3 By Type - Global Complex Injectable Revenue Market Share, 2017-2028
4.3 By Type - Global Complex Injectable Sales & Forecasts
  4.3.1 By Type - Global Complex Injectable Sales, 2017-2022
  4.3.2 By Type - Global Complex Injectable Sales, 2023-2028
  4.3.3 By Type - Global Complex Injectable Sales Market Share, 2017-2028
4.4 By Type - Global Complex Injectable Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Complex Injectable Market Size, 2021 & 2028
  5.1.2 Hospitals And Clinics
  5.1.3 Home Care Settings
  5.1.4 Online Pharmacies
  5.1.5 Others
5.2 By Application - Global Complex Injectable Revenue & Forecasts
  5.2.1 By Application - Global Complex Injectable Revenue, 2017-2022
  5.2.2 By Application - Global Complex Injectable Revenue, 2023-2028
  5.2.3 By Application - Global Complex Injectable Revenue Market Share, 2017-2028
5.3 By Application - Global Complex Injectable Sales & Forecasts
  5.3.1 By Application - Global Complex Injectable Sales, 2017-2022
  5.3.2 By Application - Global Complex Injectable Sales, 2023-2028
  5.3.3 By Application - Global Complex Injectable Sales Market Share, 2017-2028
5.4 By Application - Global Complex Injectable Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Complex Injectable Market Size, 2021 & 2028
6.2 By Region - Global Complex Injectable Revenue & Forecasts
  6.2.1 By Region - Global Complex Injectable Revenue, 2017-2022
  6.2.2 By Region - Global Complex Injectable Revenue, 2023-2028
  6.2.3 By Region - Global Complex Injectable Revenue Market Share, 2017-2028
6.3 By Region - Global Complex Injectable Sales & Forecasts
  6.3.1 By Region - Global Complex Injectable Sales, 2017-2022
  6.3.2 By Region - Global Complex Injectable Sales, 2023-2028
  6.3.3 By Region - Global Complex Injectable Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Complex Injectable Revenue, 2017-2028
  6.4.2 By Country - North America Complex Injectable Sales, 2017-2028
  6.4.3 US Complex Injectable Market Size, 2017-2028
  6.4.4 Canada Complex Injectable Market Size, 2017-2028
  6.4.5 Mexico Complex Injectable Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Complex Injectable Revenue, 2017-2028
  6.5.2 By Country - Europe Complex Injectable Sales, 2017-2028
  6.5.3 Germany Complex Injectable Market Size, 2017-2028
  6.5.4 France Complex Injectable Market Size, 2017-2028
  6.5.5 U.K. Complex Injectable Market Size, 2017-2028
  6.5.6 Italy Complex Injectable Market Size, 2017-2028
  6.5.7 Russia Complex Injectable Market Size, 2017-2028
  6.5.8 Nordic Countries Complex Injectable Market Size, 2017-2028
  6.5.9 Benelux Complex Injectable Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Complex Injectable Revenue, 2017-2028
  6.6.2 By Region - Asia Complex Injectable Sales, 2017-2028
  6.6.3 China Complex Injectable Market Size, 2017-2028
  6.6.4 Japan Complex Injectable Market Size, 2017-2028
  6.6.5 South Korea Complex Injectable Market Size, 2017-2028
  6.6.6 Southeast Asia Complex Injectable Market Size, 2017-2028
  6.6.7 India Complex Injectable Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Complex Injectable Revenue, 2017-2028
  6.7.2 By Country - South America Complex Injectable Sales, 2017-2028
  6.7.3 Brazil Complex Injectable Market Size, 2017-2028
  6.7.4 Argentina Complex Injectable Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Complex Injectable Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Complex Injectable Sales, 2017-2028
  6.8.3 Turkey Complex Injectable Market Size, 2017-2028
  6.8.4 Israel Complex Injectable Market Size, 2017-2028
  6.8.5 Saudi Arabia Complex Injectable Market Size, 2017-2028
  6.8.6 UAE Complex Injectable Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 Eli Lilly
  7.1.1 Eli Lilly Corporate Summary
  7.1.2 Eli Lilly Business Overview
  7.1.3 Eli Lilly Complex Injectable Major Product Offerings
  7.1.4 Eli Lilly Complex Injectable Sales and Revenue in Global (2017-2022)
  7.1.5 Eli Lilly Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Complex Injectable Major Product Offerings
  7.2.4 Pfizer Complex Injectable Sales and Revenue in Global (2017-2022)
  7.2.5 Pfizer Key News
7.3 Teva Pharmaceutical Industries
  7.3.1 Teva Pharmaceutical Industries Corporate Summary
  7.3.2 Teva Pharmaceutical Industries Business Overview
  7.3.3 Teva Pharmaceutical Industries Complex Injectable Major Product Offerings
  7.3.4 Teva Pharmaceutical Industries Complex Injectable Sales and Revenue in Global (2017-2022)
  7.3.5 Teva Pharmaceutical Industries Key News
7.4 Hospira
  7.4.1 Hospira Corporate Summary
  7.4.2 Hospira Business Overview
  7.4.3 Hospira Complex Injectable Major Product Offerings
  7.4.4 Hospira Complex Injectable Sales and Revenue in Global (2017-2022)
  7.4.5 Hospira Key News
7.5 Hikma Pharmaceutical
  7.5.1 Hikma Pharmaceutical Corporate Summary
  7.5.2 Hikma Pharmaceutical Business Overview
  7.5.3 Hikma Pharmaceutical Complex Injectable Major Product Offerings
  7.5.4 Hikma Pharmaceutical Complex Injectable Sales and Revenue in Global (2017-2022)
  7.5.5 Hikma Pharmaceutical Key News
7.6 Johnson & Johnson Pharmaceutical
  7.6.1 Johnson & Johnson Pharmaceutical Corporate Summary
  7.6.2 Johnson & Johnson Pharmaceutical Business Overview
  7.6.3 Johnson & Johnson Pharmaceutical Complex Injectable Major Product Offerings
  7.6.4 Johnson & Johnson Pharmaceutical Complex Injectable Sales and Revenue in Global (2017-2022)
  7.6.5 Johnson & Johnson Pharmaceutical Key News
7.7 Novo Nordisk
  7.7.1 Novo Nordisk Corporate Summary
  7.7.2 Novo Nordisk Business Overview
  7.7.3 Novo Nordisk Complex Injectable Major Product Offerings
  7.7.4 Novo Nordisk Complex Injectable Sales and Revenue in Global (2017-2022)
  7.7.5 Novo Nordisk Key News
7.8 Abbvie
  7.8.1 Abbvie Corporate Summary
  7.8.2 Abbvie Business Overview
  7.8.3 Abbvie Complex Injectable Major Product Offerings
  7.8.4 Abbvie Complex Injectable Sales and Revenue in Global (2017-2022)
  7.8.5 Abbvie Key News

8 GLOBAL COMPLEX INJECTABLE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Complex Injectable Production Capacity, 2017-2028
8.2 Complex Injectable Production Capacity of Key Manufacturers in Global Market
8.3 Global Complex Injectable Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 COMPLEX INJECTABLE SUPPLY CHAIN ANALYSIS

10.1 Complex Injectable Industry Value Chain
10.2 Complex Injectable Upstream Market
10.3 Complex Injectable Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Complex Injectable Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Complex Injectable in Global Market
Table 2. Top Complex Injectable Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Complex Injectable Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Complex Injectable Revenue Share by Companies, 2017-2022
Table 5. Global Complex Injectable Sales by Companies, (K Units), 2017-2022
Table 6. Global Complex Injectable Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Complex Injectable Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers Complex Injectable Product Type
Table 9. List of Global Tier 1 Complex Injectable Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complex Injectable Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Complex Injectable Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Complex Injectable Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Complex Injectable Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Complex Injectable Sales (K Units), 2017-2022
Table 15. By Type - Global Complex Injectable Sales (K Units), 2023-2028
Table 16. By Application – Global Complex Injectable Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Complex Injectable Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Complex Injectable Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Complex Injectable Sales (K Units), 2017-2022
Table 20. By Application - Global Complex Injectable Sales (K Units), 2023-2028
Table 21. By Region – Global Complex Injectable Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Complex Injectable Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Complex Injectable Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Complex Injectable Sales (K Units), 2017-2022
Table 25. By Region - Global Complex Injectable Sales (K Units), 2023-2028
Table 26. By Country - North America Complex Injectable Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Complex Injectable Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Complex Injectable Sales, (K Units), 2017-2022
Table 29. By Country - North America Complex Injectable Sales, (K Units), 2023-2028
Table 30. By Country - Europe Complex Injectable Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Complex Injectable Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Complex Injectable Sales, (K Units), 2017-2022
Table 33. By Country - Europe Complex Injectable Sales, (K Units), 2023-2028
Table 34. By Region - Asia Complex Injectable Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Complex Injectable Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Complex Injectable Sales, (K Units), 2017-2022
Table 37. By Region - Asia Complex Injectable Sales, (K Units), 2023-2028
Table 38. By Country - South America Complex Injectable Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Complex Injectable Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Complex Injectable Sales, (K Units), 2017-2022
Table 41. By Country - South America Complex Injectable Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Complex Injectable Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Complex Injectable Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Complex Injectable Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Complex Injectable Sales, (K Units), 2023-2028
Table 46. Eli Lilly Corporate Summary
Table 47. Eli Lilly Complex Injectable Product Offerings
Table 48. Eli Lilly Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Pfizer Corporate Summary
Table 50. Pfizer Complex Injectable Product Offerings
Table 51. Pfizer Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Teva Pharmaceutical Industries Corporate Summary
Table 53. Teva Pharmaceutical Industries Complex Injectable Product Offerings
Table 54. Teva Pharmaceutical Industries Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. Hospira Corporate Summary
Table 56. Hospira Complex Injectable Product Offerings
Table 57. Hospira Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Hikma Pharmaceutical Corporate Summary
Table 59. Hikma Pharmaceutical Complex Injectable Product Offerings
Table 60. Hikma Pharmaceutical Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Johnson & Johnson Pharmaceutical Corporate Summary
Table 62. Johnson & Johnson Pharmaceutical Complex Injectable Product Offerings
Table 63. Johnson & Johnson Pharmaceutical Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Novo Nordisk Corporate Summary
Table 65. Novo Nordisk Complex Injectable Product Offerings
Table 66. Novo Nordisk Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Abbvie Corporate Summary
Table 68. Abbvie Complex Injectable Product Offerings
Table 69. Abbvie Complex Injectable Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. Complex Injectable Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 71. Global Complex Injectable Capacity Market Share of Key Manufacturers, 2020-2022
Table 72. Global Complex Injectable Production by Region, 2017-2022 (K Units)
Table 73. Global Complex Injectable Production by Region, 2023-2028 (K Units)
Table 74. Complex Injectable Market Opportunities & Trends in Global Market
Table 75. Complex Injectable Market Drivers in Global Market
Table 76. Complex Injectable Market Restraints in Global Market
Table 77. Complex Injectable Raw Materials
Table 78. Complex Injectable Raw Materials Suppliers in Global Market
Table 79. Typical Complex Injectable Downstream
Table 80. Complex Injectable Downstream Clients in Global Market
Table 81. Complex Injectable Distributors and Sales Agents in Global Market

List Of Figures

LIST OF FIGURES

Figure 1. Complex Injectable Segment by Type
Figure 2. Complex Injectable Segment by Application
Figure 3. Global Complex Injectable Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Complex Injectable Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Complex Injectable Revenue, 2017-2028 (US$, Mn)
Figure 7. Complex Injectable Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Complex Injectable Revenue in 2021
Figure 9. By Type - Global Complex Injectable Sales Market Share, 2017-2028
Figure 10. By Type - Global Complex Injectable Revenue Market Share, 2017-2028
Figure 11. By Type - Global Complex Injectable Price (USD/Unit), 2017-2028
Figure 12. By Application - Global Complex Injectable Sales Market Share, 2017-2028
Figure 13. By Application - Global Complex Injectable Revenue Market Share, 2017-2028
Figure 14. By Application - Global Complex Injectable Price (USD/Unit), 2017-2028
Figure 15. By Region - Global Complex Injectable Sales Market Share, 2017-2028
Figure 16. By Region - Global Complex Injectable Revenue Market Share, 2017-2028
Figure 17. By Country - North America Complex Injectable Revenue Market Share, 2017-2028
Figure 18. By Country - North America Complex Injectable Sales Market Share, 2017-2028
Figure 19. US Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Complex Injectable Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Complex Injectable Sales Market Share, 2017-2028
Figure 24. Germany Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 25. France Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Complex Injectable Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Complex Injectable Sales Market Share, 2017-2028
Figure 33. China Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 37. India Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Complex Injectable Revenue Market Share, 2017-2028
Figure 39. By Country - South America Complex Injectable Sales Market Share, 2017-2028
Figure 40. Brazil Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Complex Injectable Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Complex Injectable Sales Market Share, 2017-2028
Figure 44. Turkey Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Complex Injectable Revenue, (US$, Mn), 2017-2028
Figure 48. Global Complex Injectable Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Complex Injectable by Region, 2021 VS 2028
Figure 50. Complex Injectable Industry Value Chain
Figure 51. Marketing Channels